Organisations question EC changes on drug information for patientsBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b894 (Published 04 March 2009) Cite this as: BMJ 2009;338:b894
- Rory Watson
Medical and consumer organisations are raising concerns about plans by the European Commission to allow drug companies to provide information on prescription only drugs directly to the public. The drug industry is also questioning how the system would work in practice.
The initial reactions to measures that would allow drug companies to supply factual information on prescription only drugs to the public emerged last week at a conference in Brussels organised by the European Commission and the Organisation for Professionals in Regulatory Affairs.
The draft legislation, tabled last December, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial